The discovery of early detection and standardization are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathological evaluation. The platform can assist in linking a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment.
Treatment and management of prognosis of delayed prognosis of carcinogenesis require individualized management, usually including drug therapy, rehabilitation, regular visits, and more. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult-to-treat genetic metabolic disorders have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, with timely adjustments according to changes in the disease.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of the slow growth associated with carcinoma deficiency. 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.